Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array

International Journal of Cancer

Volumn 119, Issue 3, 2006, Pages 571-578

  Benetkiewicz, Magdalena ^a   Díaz De Ståhl, Teresita ^a   Gördör, Anita ^b   Pfeifer, Susan ^b   Wittmann, Stefanie ^c   Gessler, Manfred ^c   Dumanski, Jan P ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Chromosome 22; Complex amplifier genotype; Genomic array; Minimal common overlapping regions; Wilms' tumor

Indexed keywords

DNA;

ALLELIC IMBALANCE; ARTICLE; CANCER RELAPSE; CHILDHOOD CANCER; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENE MAPPING; FATALITY; GENE AMPLIFICATION; GENE NUMBER; GENOMIC ARRAY; GENOMIC IMBALANCE; GENOMICS; GENOTYPE; HEMIZYGOSITY; HUMAN; HUMAN TISSUE; METASTASIS; NEPHROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; TILING PATH CHROMOSOME ARRAY; TUMOR SUPPRESSOR GENE;

CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; DNA, NEOPLASM; FEMALE; GENOME, HUMAN; GENOTYPE; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; MONOSOMY; NUCLEIC ACID HYBRIDIZATION; WILMS TUMOR;

EID: 33745446367     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21868     Document Type: Article

References (41)

1. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol 1993;21:172-81.
2. McLorie GA. Wilms tumor (nephroblastoma). Curr Opin Urol 2001;11:567-70.
3. Charles AK, Vujanic GM, Berry PJ. Renal tumours of childhood. Histopathology 1998;32:293-309.
4. Coppes MJ, Wilson PC, Weitzman S. Extrarenal Wilms tumor: staging, treatment, and prognosis. J Clin Oncol 1991;9:167-74.
5. Green DM, D'Angio GJ, Beckwith JB, Breslow NE, Grundy PE, Ritchey ML, Thomas PR. Wilms tumor. CA Cancer J Clin 1996;46:46-4.
6. Jones KP, Grundy PE, Coppes MJ. Recent advances in the genetics of childhood renal cancers: a report of the 3rd International Conference on the molecular and clinical genetics of childhood renal tumors, together with the Mitchell Ross symposium on anaplastic and other high risk embryonal tumors of childhood, 8-10th April 1999, Wistar Institute, Philadelphia, PA. Med Pediatr Oncol 2000;35:126-30.
7. Vujanic GM, Sandstedt B, Harms D, Kelsey A, Leuschner I, de Kraker J. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002;38:79-82.
8. Bove KE. Wilms tumor and related abnormalities in the fetus and newborn. Semin Perinatol 1999;23:310-18.
9. Porteus MH, Narkool P, Neuberg D, Guthrie K, Breslow N, Green DM, Diller L. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 2000;18:2026-31.
10. McTaggart SJ, Algar E, Chow CW, Powell HR, Jones CL. Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol 2001;16:335-9.
11. Breslow NE, Norris R, Norkool PA, Kang T, Beckwith JB, Perlman EJ, Ritchey ML, Green DM, Nichols KE. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol 2003;21:4579-85.
12. Huff V. Wilms tumor genetics. Am J Med Genet 1998;79:260-7.
13. Takahashi M, Yang XJ, Lavery TT, Purge KA, Williams BO, Tretiakova M, Montag A, Vogelzang NJ, Re GG, Garvin AJ, Soderhall S, Kagawa S, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 2002;62:6598-605.
14. Peres EM, Savasan S, Cushing B, Abella S, Mohamed AN. Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology. Cancer Genet Cytogenet 2004;148:66-70.
15. Ghanem MA, van Steenbrugge GJ, Nijman RJ, van der Kwast TH. Prognostic markers in nephroblastoma (Wilms' tumor). Urology 2005;65:1047-54.
16. Klamt B, Schulze M, Thate C, Mares J, Goetz P, Kodet R, Scheulen W, Weirich A, Graf N, Gessler M. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters. Genes Chromosomes Cancer 1998;22:287-94.
17. Kullendorff CM, Soller M, Wiebe T, Mertens F. Cytogenetic findings and clinical course in a consecutive series of Wilms tumors. Cancer Genet Cytogenet 2003;140:82-7.
18. Austruy E, Candon S, Henry I, Gyapay G, Tournade MF, Mannens M, Callen D, Junien C, Jeanpierre C. Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis. Genes Chromosomes Cancer 1995;14:285-94.
19. Bown N, Cotterill SJ, Roberts P, Griffiths M, Larkins S, Hibbert S, Middleton H, Kelsey A, Tritton D, Mitchell C. Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 2002;38:11-21.
20. Buckley PG, Mantripragada KK, Benetkiewicz M, Tapia-Paez I, Diaz De Stahl T, Rosenquist M, Ali H, Jarbo C, De Bustos C, Hirvela C, Sinder Wilen B, Fransson I, et al. A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Hum Mol Genet 2002;11:3221-9.
21. Sambrook J, Fritsch E, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
22. Reinhard H, Semler O, Burger D, Bode U, Flentje M, Gobel U, Gutjahr P, Leuschner I, Maass E, Niggli F, Scheel-Walter HG, Stockle M, et al. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms tumor. Klin Padiatr 2004;216:132-40.
23. Bruder CE, Ichimura K, Blennow E, Ikeuchi T, Yamaguchi T, Yuasa Y, Collins VP, Dumanski JP. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene? Genes Chromosomes Cancer 1999;25:184-90.
24. Fujise K, Zhang D, Liu J, Yeh ET. Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J Biol Chem 2000;275:39458-65.
25. Wang PJ, McCarrey JR, Yang F, Page DC. An abundance of X-linked genes expressed in spermatogonia. Nat Genet 2001;27:422-6.
26. Wilson HL, Wong AC, Shaw SR, Tse WY, Stapleton GA, Phelan MC, Hu S, Marshall J, McDermid HE. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 2003;40:575-84.
27. Urch UA. Biochemistry and function of acrosin. Boca Raton, FL: CRC, 1991.
28. Hing S, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K. Gain of 1q is associated with adverse outcome in favorable histology Wilms tumors. Am J Pathol 2001;158:393-8.
29. Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms tumors. Mol Cancer Res 2005;3:493-502.
30. Seng TJ, Ichimura K, Liu L, Tingby O, Pearson DM, Collins VP. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer 2005;43:181-93.
31. Harvey BP, Banga SS, Ozer HL. Regulation of the multifunctional Ca2+/calmodulin-dependent protein kinase II by the PP2C phosphatase PPM1F in fibroblasts. J Biol Chem 2004;279:24889-98.
32. Li W, Wang JC. Mammalian DNA topoisomerase IIIα is essential in early embryogenesis. Proc Natl Acad Sci USA 1998;95:1010-13.
33. de Stahl TD, Hartmann C, de Bustos C, Piotrowski A, Benetkiewicz M, Mantripragada KK, Tykwinski T, von Deimling A, Dumanski JP. Chromosome 22 tiling-path array-CGH analysis identifies germ-line-and tumor-specific aberrations in patients with glioblastoma multiforme. Genes Chromosomes Cancer 2005;44:161-9.
34. de Ståhl TD, Hanison CM, de Bustos C, Mantripragada KK, Piotrowski A, Benetkiewicz M, Jarbo C, Wiklund L, Mathiesen T, Nyberg G, Collins VP, Evans DG, Ichimura K. High-resolution array-CGH profiling of germline and tumor- specific copy number alterations on chromosome 22 in patients affected with schwannomas. Hum genet, in press.
35. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. Detection of large-scale variation in the human genome. Nat Genet 2004;36:949-51.
36. Ammerlaan AC, de Bustos C, Ararou A, Buckley PG, Mantripragada KK, Verstegen MJ, Hulsebos TJ, Dumanski JP. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray. Genes Chromosomes Cancer 2005;43:329-38.
37. Buckley PG, Mantripragada KK, Diaz de Stahl T, Piotrowski A, Hansson CM, Kiss H, Vetrie D, Ernberg IT, Nordenskjold M, Bolund L, Sainio M, Rouleau GA, et al. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat 2005;26:540-9.
38. Benetkiewicz M, Wang Y, Schaner M, Wang P, Mantripragada KK, Buckley PG, Kristensen G, Borresen-Dale AL, Dumanski JP. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas. Genes Chromosomes Cancer 2005;42:228-37.
39. Jarbo C, Buckley PG, Piotrowski A, Mantripragada KK, Benetkiewicz M, de Sthal TD, Langford CF, Gregory SG, Gimm O, Bäckdahl M, Geli J, Larsson C, et al. Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH. Int J Cancer 2006;118:1159-64.
40. Stock C, Ambros IM, Lion T, Zoubek A, Amann G, Gadner H, Ambros PF. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance. Cancer Genet Cytogenet 2002;135:128-38.
41. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, Ling V, MacAulay C, et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004;36:299-303.